QA: Lexicon Pharmaceuticals INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001062822_2016_Lexicon_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001062822, Lexicon Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 532,400,000
1 IntangibleAssetsNetIncludingGoodwill 44,543,000
2 PropertyPlantAndEquipmentNet 21,227,000
3 remainder_Assets 56,662,000
4 LiabilitiesCurrent 122,996,000
5 LiabilitiesNoncurrent 118,160,000
6 remainder_Liabilities 127,826,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 23,907,813
9 ResearchAndDevelopmentExpense 94,613,741
10 remainder_Expenses 16,386,126
11 remainder_Revenues 665,684,372
12 remainder_NetIncome 1,673,720
13 remainder_ComprehensiveNetIncome -610,999
  yvar yval
0 Assets 654,832,000
1 Liabilities 368,982,000
2 Expenses 134,907,680
3 Revenues 665,684,372
4 StockholdersEquity 285,850,000
5 NetIncome 532,450,412
6 ComprehensiveNetIncome 532,144,912
7 BaseVar 913,345,386
8 EconomicCapitalRatiobeforeLimitedLiability 2.26
9 EconomicCapitalRatio 3.20

Edgar->Model Mapping

Feature Distribution

Change over Time